SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 25, 17:00
2745.85
35.3 (1.3%)
VOLUME 27,837
LIVE
NSE
Jul 16, 16:05
2647.20
8.35 (0.32%)
VOLUME 253,809
News on Dr Reddys Laboratories
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Dr Reddy's Laboratories: Kunal Bothra 

3.41 pm | 25 Jul 2014 |  Source: CNBC-TV18

Kunal Bothra, Head of Advisory at LKP recommends buying Dr Reddy's Laboratories with a target of Rs 2820....

Expect Dr Reddy's Labs to cross Rs 2950: Ashish Chaturmohta 

4.11 pm | 22 Jul 2014 |  Source: CNBC-TV18

Ashish Chaturmohta of Fortune Equity Broker feels that Dr Reddy's Laboratories may cross Rs 2950....

Positive on private banks like ICICI: Ashish Chaturmohta 

2.40 pm | 22 Jul 2014 |  Source: CNBC-TV18

Ashish Chaturmohta of Fortune Equity Broker gives his views on Exide, ICICI Bank, Jubilant FoodWorks and Dr Reddy's....

Expect upside in Dr Reddy's Labs: Sudarshan Sukhani 

10.35 am | 21 Jul 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may see upside in Dr Reddy's Laboratories....

Pharma cos up in arms against govt's price control move 

7.54 pm | 16 Jul 2014 |  Source: CNBC-TV18

Sources suggest drug company chiefs have already started making their visits to Delhi. At least 3-4 have already sought meetings in the ministry to pu...

See more drug price caps; max impact on Sanofi: Expert 

10.09 am | 16 Jul 2014 |  Source: CNBC-TV18

NPPA has cut and capped prices of some major anti-diabetes and cardiovascular drugs that were not part of the 652 drugs earlier listed out by the gove...

See prices of cardiac drugs reduce by 15-50%: Ex-MD Pfizer 

12.12 pm | 14 Jul 2014 |  Source: CNBC-TV18

According to Kewal Handa, the pricing regulator (NPPA) has fixed prices of medicines that are not included in the national list of essential medicines...

Experts take stock of D-Street's worst week in 15-months 

3.39 pm | 12 Jul 2014 |  Source: CNBC-TV18

In an interview to CNBC-TV18's Sonia Shenoy and Anuj Singhal, Vibhav Kapoor of IL&FS spoke about the market and their outlook for next week's trade. ...

Sun Pharma, Dr Reddy's rally on strong gross sales in June

12.21 pm | 11 Jul 2014 |  Source: Moneycontrol.com

In terms of company specific growth, Sun Pharma, Cipla, Lupin, Glenmark, Dr Reddy's Labs and Ipca Labs with gross sales growth of 16.1 percent, 11.7 p...

Stocks in news: Infosys, Kotak Mahindra Bank, IL&FS Engg

8.11 am | 11 Jul 2014 |  Source: CNBC-TV18

Kotak Mahindra Bank | ITC | Infosys | Speciality Paper | Astral Poly Technik | IL&FS Engineering | Tata Communications | GMR Infrastructure | Jaipraka...

Budget 2014: Is it going to be prudent or populist?: Prabhudas Lilladher

1.48 pm | 09 Jul 2014 |  Source: Moneycontrol.com

Prabhudas Lilladher continues to maintain our market strategy of being fully invested in the market and adding at every fall in the market as we conti...

Lupin, Dr Reddys Lab top picks in pharma space: ICICIdirect

7.41 pm | 08 Jul 2014 |  Source: Moneycontrol.com

ICICIdirect.com has come out with its report on healthcare space. According to the research firm, Lupin and Dr Reddys Laboratories from the large cap ...

Dr Reddys Laboratories' AGM on July 31, 2014

10.28 pm | 07 Jul 2014 |  Source: Moneycontrol.com

Dr Reddys Laboratories has informed that the 30th Annual General Meeting (AGM) of the Company will be held on July 31, 2014....

Dr Reddys Laboratories' Q1 results on July 30, 2014

10.19 pm | 07 Jul 2014 |  Source: Moneycontrol.com

Dr Reddys Laboratories board meeting will be held on July 30, 2014, to consider and approve the Unaudited Financial Results of the Company for the qua...

Prefer Lupin, Dr Reddy's Lab: Gopi Suvanam 

11.20 am | 03 Jul 2014 |  Source: CNBC-TV18

Gopi Suvanam of InvestWorks is of the view that one may prefer Lupin and Dr Reddy's Laboratories....

Dr Reddy's gains 1%; JP Morgan overweight, sees 15% upside

10.17 am | 30 Jun 2014 |  Source: Moneycontrol.com

The brokerage is positive on Dr Reddy’s growth trajectory, given its focus on limited competition generics in the US and the bio-similars opportunit...

Top 10 stocks to focus on June 30 

8.34 am | 30 Jun 2014 |  Source: CNBC-TV18

CNBC-TV18's research team gives top 10 stocks to watch on June 30 - ICICI Bank, Glenmark Pharma, Indiabulls Real Estate, Dr Reddy's Laboaratories, Eic...

GDUFA fee: 86 generic drug approvals voluntarily withdrawn

10.10 pm | 27 Jun 2014 |  Source: CNBC-TV18

Drug companies in the US are carefully evaluating their portfolios to give away approvals for those products that are not commercially viable, as thes...

Dr Reddy's Labs gains 3%, launches anti-depression drug

3.18 pm | 27 Jun 2014 |  Source: Moneycontrol.com

Dr Reddy's Laboratories has launched duloxetine delayed-release capsules USP 20 mg, 30 mg and 60 mg in the US market on June 26....

Dr Reddy's Labs launches generic version of Cymbalta

2.55 pm | 27 Jun 2014 |  Source: PTI

Drug maker Dr Reddy's Laboratories has launched duloxetine delayed-release capsules USP 20 mg, 30 mg and 60 mg in the US market, the company said toda...

1 2 3 4 5
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.